Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15981157 | 0.93 | USP2 (0.56) | USP2HTTLPAR5PLA2G2CNAAA | |
| SCHEMBL23564645 | 0.91 | USP2 (0.53) | USP2HTTLPAR5NAAAKDM4E | |
| SCHEMBL20794136 | 0.90 | USP2 (0.50) | USP2HTTLPAR5KDM4EMEN1 | |
| SCHEMBL116830 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL932977 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL118176 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL9248716 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL21082980 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL24835077 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E | |
| SCHEMBL8856104 | 0.83 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3263093-B1 | COSMETIC COMPOSITION | AJINOMOTO KK (JP) | 2022-07-20 | — | — | EP | disclosed |
| EP-3100715-B1 | COSMETIC COMPOSITION | AJINOMOTO KK (JP) | 2019-01-02 | — | — | EP | disclosed |
| US-10117820-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2018-11-06 | — | — | US | disclosed |
| EP-3263093-A1 | COSMETIC COMPOSITION | AJINOMOTO CO., INC. (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-20160354294-A1 | COSMETIC COMPOSITION | AJINOMOTO CO., INC. (JP) | 2016-12-08 | — | — | US | disclosed |
| EP-3100715-A1 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. (JP) | 2016-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354294-A1 | COSMETIC COMPOSITION | KAT7, HDAC10, KAT5 | USP2 3345/4885HTT 540/4885LPAR5 594/4885 |
| US-10117820-B2 | Cosmetic composition | KAT7, HDAC10, KAT5 | USP2 3345/4885HTT 540/4885LPAR5 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.